Three markers of inflammation were evaluated: CRP, TNF-α, and IL-6; however, only five trials [21, 25, 35–37] evaluated CRP in T2DM following folic acid supplementation compared to placebo. The gene discussed is TNF; the disease is type 2 diabetes mellitus.